ALGN News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

AL

Mkt Cap

$10.47B

Volume

687.64K

Next Earnings

October 28th

Loading chart

AL

ALGNAlign Technology Inc

ALGN

Pay with—

Available Balance0.00

AL

Mkt Cap

$10.61B

Volume

687.64K

Next Earnings

October 28th

Chart Financials Earnings News About Insider Filings

Will Align Technology (ALGN) Beat Estimates Again in Its Next Earnings Report?Align Technology, maker of the Invisalign tooth-straightening system, is positioned to potentially beat earnings estimates in its upcoming October 28, 2026 report. The company has a strong track record of beating estimates with an average surprise of 8.64% over the past two quarters. With a positive Earnings ESP of +1.23% combined with a Zacks Rank #3 (Hold), analysts suggest another earnings beat is likely, as stocks with this combination historically beat consensus estimates nearly 70% of the time.Zacks Investment Research · Oct 2, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarThe article highlights two medical stocks with positive Earnings Surprise Prediction (ESP) metrics that could outperform expectations: Align Technology (ALGN) with a +1.23% ESP ahead of October 28 earnings, and Iovance Biotherapeutics (IOVA) with a +22.22% ESP before November 5 earnings. Both stocks hold a Zacks Rank #3 (Hold) rating, and positive ESP combined with favorable rankings historically produce positive surprises 70% of the time.Zacks Investment Research · Oct 2, 2026

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin PressureDENTSPLY SIRONA (XRAY) exceeded Q2 earnings and revenue estimates with adjusted EPS of 52 cents versus 36 cents consensus, though revenues fell 4.1% year-over-year. The company maintained full-year 2026 guidance of $3.5-3.6B in sales and $1.40-1.50 adjusted EPS. Wellspect Healthcare grew 7.1%, but three dental segments declined, with tariff pressures and lower volumes constraining operating margins. Free cash flow improved to $55M from $16M year-ago.Zacks Investment Research · Sep 8, 2026

Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?Cardinal Health is leveraging technology investments across distribution, specialty services, and logistics to operate as a tech-enabled healthcare platform. The company integrated Sonexus into its Nuclear business web-ordering platform for end-to-end digital workflows, achieved a 99% fill rate, and plans $700 million in fiscal 2027 capital spending. Peers CONMED and Align Technology are similarly expanding their technology-driven healthcare solutions.Zacks Investment Research · Sep 8, 2026

Here's How CVS' Improving Balance Sheet Supports DeleveragingCVS Health generated $10.6B in YTD operating cash flow and raised its full-year outlook to at least $11.5B, ending Q2 with $2.7B in cash. The company maintains a leverage ratio of 3.5x and expects improvement as it prioritizes balance-sheet strengthening over share buybacks in 2026-2027. Peers Align Technology and Cardinal Health also demonstrate strong liquidity positions with active capital deployment strategies.Zacks Investment Research · Sep 2, 2026

7 S&P 500 Stocks That Remain on Sale Despite the Index’s Record HighsWhile the S&P 500 reaches record highs driven primarily by large technology companies trading at elevated valuations, several S&P 500 stocks have lagged behind and are trading at significant discounts of 27-61% below fair value estimates. These undervalued stocks, including gold producers and healthcare companies, present potential catch-up opportunities as investors seek alternatives to expensive mega-cap tech stocks.Investing.com · May 26, 2026

Align Technology Shares Jump Following Report Of Large Elliott PositionActivist investor Elliott Investment Management has taken a large stake in Align Technology (ALGN), positioning itself to push for strategic changes to boost shareholder value. The move comes as Align struggles with weakened demand post-pandemic, though Q4 2025 showed record Invisalign volumes. Barclays upgraded the stock to Overweight with a $200 price target, citing recovery potential as geopolitical concerns stabilize and the stock trades below historical valuation multiples.Benzinga · Mar 19, 2026

Global Shift to Clear Aligners to Build a USD 99.44 Billion Market by 2034The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow fastest. Key drivers include rising demand for aesthetic orthodontic solutions, technological advancements in 3D imaging and AI, and expanding access through digital platforms.GlobeNewswire Inc. · Feb 10, 2026

Growth of the Invisible Orthodontics Market From USD 7.7 Billion in 2024 to USD 96.27 Billion by 2034, Driven by a CAGR of 28.54%The global invisible orthodontics market is projected to grow from USD 9.91 billion in 2025 to USD 96.27 billion by 2034, expanding at a CAGR of 28.54%. Clear aligners dominate the product segment, with North America leading regionally and Asia-Pacific showing significant growth potential. Adults currently represent the largest age segment, while the teens segment is expected to grow rapidly. Key drivers include rising dental misalignment cases, technological advancements in 3D printing, and increased consumer awareness of aesthetic dental solutions.GlobeNewswire Inc. · Feb 5, 2026

Align Tech Invisalign Volumes Hit RecordsAlign Technology reported record Invisalign case submissions in Q4 with 87.7 thousand doctors submitting cases. Revenue beat expectations at $1.048 billion (+5.3% YoY) and adjusted EPS of $3.29 surpassed consensus of $2.97. The company projects 3-4% revenue growth for fiscal 2026 with improving margins, sending shares up 10.43% in premarket trading.Benzinga · Feb 5, 2026

to start trading

AL

ALGNAlign Technology Inc

ALGN

Pay with—

Available Balance0.00

Your PositionYou don't own any ALGN yet.

Related Tickers

Earnings